The CNSA QLD&NT State Group invite all members and non-members to their upcoming hybrid educational event, which will bring together nurses from across the state to explore how tumour somatic mutations, particularly KRAS in colorectal cancer, influence treatment and patient care. A session with our medical colleagues will share how disease characteristics and mutational status impacts clinical decision-making and pathways of care.
Following the medical perspectives, a pharmacist will share perspective on targeted therapies and supportive medicines. Lastly, a joint session with a bowel cancer nurse and consumer will provide perspectives on supportive care during and after cancer treatment, offering an authentic voice on the lived experience of colorectal cancer.
With speakers joining from various locations and sessions live-streamed for wider participation, this event is designed as both an educational forum and a networking opportunity, connecting nursing professionals across the state in advancing personalised colorectal cancer care.